Amantadine hydrochloride in the treatment of Parkinson's disease.
D000328:Adult; D000368:Aged; D000547:Amantadine / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos; D004856:Postural Balance; D013997:Time Factors; D014717:Vertigo / Q000139:chemically induced
D010919:Placebos; D000547:Amantadine